StemCell Institute Inc. (TYO:7096)

Market Cap	9.80B
Revenue (ttm)	2.70B
Net Income (ttm)	250.00M
Shares Out	10.25M
EPS (ttm)	24.46
PE Ratio	39.08
Forward PE	n/a
Dividend	25.00 (2.62%)
Ex-Dividend Date	Sep 27, 2024

Volume	86,300
Average Volume	52,985
Open	943.00
Previous Close	928.00
Day's Range	921.00 - 967.00
52-Week Range	911.00 - 1,923.00
Beta	0.53
RSI	44.13
Earnings Date	Nov 7, 2025

About StemCell Institute

StemCell Institute Inc. engages in the stem cell banking business in Japan. The company is also involved in research and development of medical treatments using stem cells, as well as engages in banking of blood vessel cells businesses. StemCell Institute Inc. was incorporated in 1999 and is headquartered in Tokyo, Japan. StemCell Institute Inc. is a subsidiary of Trim Medical Holdings Inc.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1999
• Employees: 117
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 7096

Financial Performance

In 2024, StemCell Institute's revenue was 2.68 billion, an increase of 7.98% compared to the previous year's 2.48 billion. Earnings were 385.00 million, an increase of 24.19%.